Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.00024 | 1 |
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -8.4e-05 | 1 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 4.5e-05 | 1 |
mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -6.3e-06 | 1 |